Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark V Mishra

Showing results (11-20 of 100) with videos related to

Pageof 10
Sort By:
Cureus|October 25, 2021
Factors Related to Small- and Mid-Capitalization Pharmaceutical Company Success Using Stock Performance as a SurrogateMatthew J Ferris, Kai Sun, Corey Savard, et al.
Medical Physics|April 21, 2025
Interpretable AI-assisted clinical decision making for treatment selection for brain metastases in radiation therapyYufeng Cao, Hua-Ren Cherng, Dan Kunaprayoon, et al.
Journal of Medical Imaging and Radiation Oncology|June 24, 2011
Safety and efficacy of radiation therapy as secondary prophylaxis for heterotopic ossification of non-hip jointsMark V Mishra, Luke Austin, Javad Parvizi, et al.
International Journal of Radiation Oncology, Biology, Physics|September 27, 2024
An Exploratory Analysis of the Conditional Neurocognitive Function Failure Risk in Patients Receiving Whole Brain Radiation Therapy for Brain Metastases on NRG Oncology CC001Hua-Ren R Cherng, Kai Sun, Soren M Bentzen, et al.
International Journal of Radiation Oncology, Biology, Physics|January 25, 2012
The impact of brachytherapy on prostate cancer-specific mortality for definitive radiation therapy of high-grade prostate cancer: a population-based analysisXinglei Shen, Scott W Keith, Mark V Mishra, et al.
Cancers|February 25, 2022
Administering Docetaxel for Metastatic Hormone-Sensitive Prostate Cancer 1-6 Days Compared to More Than 14 Days after the Start of LHRH Agonist Is Associated with Better Clinical Outcomes Due to Androgen FlareNicola J Nasser, Kai Sun, Karen M Scanlon, et al.
American Journal of Clinical Oncology|March 7, 2018
Targeting Tumor Metabolism With Statins During Treatment for Advanced-stage Pancreatic CancerNick A Iarrobino, Beant Gill, Mark E Bernard, et al.
Seminars in Radiation Oncology|June 24, 2018
How Histopathologic Tumor Extent and Patterns of Recurrence Data Inform the Development of Radiation Therapy Treatment Volumes in Solid MalignanciesArpit Chhabra, Craig Schneider, Mudit Chowdhary, et al.
Brachytherapy|July 14, 2015
Evaluation of brachytherapy and external beam radiation therapy for early stage, node-negative uterine carcinosarcomaNirav Patel, Sarah E Hegarty, Leigh A Cantrell, et al.
Current Opinion in Oncology|April 5, 2021
High-risk, recurrent and oligometastatic prostate cancer: recent developments on the role of radiationJason K Molitoris, Gregory S Alexander, Osman Siddiqui, et al.
Pageof 10

Showing results (11-20 of 100) with videos related to

Sort By:
Pageof 10
Cureus|October 25, 2021
Factors Related to Small- and Mid-Capitalization Pharmaceutical Company Success Using Stock Performance as a SurrogateMatthew J Ferris, Kai Sun, Corey Savard, et al.
Medical Physics|April 21, 2025
Interpretable AI-assisted clinical decision making for treatment selection for brain metastases in radiation therapyYufeng Cao, Hua-Ren Cherng, Dan Kunaprayoon, et al.
Journal of Medical Imaging and Radiation Oncology|June 24, 2011
Safety and efficacy of radiation therapy as secondary prophylaxis for heterotopic ossification of non-hip jointsMark V Mishra, Luke Austin, Javad Parvizi, et al.
International Journal of Radiation Oncology, Biology, Physics|September 27, 2024
An Exploratory Analysis of the Conditional Neurocognitive Function Failure Risk in Patients Receiving Whole Brain Radiation Therapy for Brain Metastases on NRG Oncology CC001Hua-Ren R Cherng, Kai Sun, Soren M Bentzen, et al.
International Journal of Radiation Oncology, Biology, Physics|January 25, 2012
The impact of brachytherapy on prostate cancer-specific mortality for definitive radiation therapy of high-grade prostate cancer: a population-based analysisXinglei Shen, Scott W Keith, Mark V Mishra, et al.
Cancers|February 25, 2022
Administering Docetaxel for Metastatic Hormone-Sensitive Prostate Cancer 1-6 Days Compared to More Than 14 Days after the Start of LHRH Agonist Is Associated with Better Clinical Outcomes Due to Androgen FlareNicola J Nasser, Kai Sun, Karen M Scanlon, et al.
American Journal of Clinical Oncology|March 7, 2018
Targeting Tumor Metabolism With Statins During Treatment for Advanced-stage Pancreatic CancerNick A Iarrobino, Beant Gill, Mark E Bernard, et al.
Seminars in Radiation Oncology|June 24, 2018
How Histopathologic Tumor Extent and Patterns of Recurrence Data Inform the Development of Radiation Therapy Treatment Volumes in Solid MalignanciesArpit Chhabra, Craig Schneider, Mudit Chowdhary, et al.
Brachytherapy|July 14, 2015
Evaluation of brachytherapy and external beam radiation therapy for early stage, node-negative uterine carcinosarcomaNirav Patel, Sarah E Hegarty, Leigh A Cantrell, et al.
Current Opinion in Oncology|April 5, 2021
High-risk, recurrent and oligometastatic prostate cancer: recent developments on the role of radiationJason K Molitoris, Gregory S Alexander, Osman Siddiqui, et al.
Pageof 10